A drug utilisation post-authorisation study of new users of aclidinium bromide (monotherapy or in combination)

Trial Identifier: D6560R00005
Sponsor: AstraZeneca
Collaborator:
RTI Health Solutions
NCTID:: NCT03333018
Start Date: July 2015
Primary Completion Date: February 2017
Study Completion Date: February 2017
Condition: Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Denmark Odense, Denmark
Germany Bremen, Germany
United Kingdom London, United Kingdom